Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
Championing Bispecific Antibodies in the VA
Bispecific antibodies (BsAbs) are an emerging and fast-developing area of immunotherapy, particularly in the treatment of hematologic malignancies. However, access to this therapy remains limited,…
Data-Driven Toxicity Management for ADCs
Toxicities related to antibody-drug conjugates (ADCs) can significantly impact quality of life for patients with locally advanced or metastatic bladder cancer, but data-driven programs can help…
Advancing Cancer Care Worldwide: ACCC Global eXchange
The ACCC Global eXchange series is committed to highlighting cross-regional collaborations that advance cancer care delivery and workforce development nationwide. In this episode of CANCER BUZZ, Dr.…
Designing Care That Creates Value for Patients and the Health System
At the inaugural ACCC Leadership Summit, C-suite executives and senior-level decision makers in oncology convened for strategic dialogue, panel discussions, and peer-to-peer exchange focused on the…
A Collaborative Approach to Health Policy Changes
At the inaugural ACCC Leadership Summit, C-suite executives and senior-level decision makers in oncology convened for strategic dialogue, panel discussions, and peer-to-peer exchange focused on the…
Closing the Gap Between Innovation and Implementation: Strategic Partnerships in Oncology
At the inaugural ACCC Leadership Summit, C-suite executives and senior-level decision makers in oncology convened for strategic dialogue, engaging panel discussions, and peer-to-peer exchange focused…
Becoming a Smart Consumer of AI as an Oncology Leader
At the inaugural ACCC Leadership Summit, C-suite executives and senior-level decision makers in oncology convened for strategic dialogue, engaging panel discussions, and peer-to-peer exchange focused…
BsAbs: Moving from Curiosity to Confidence
Indications for the use of bispecific antibodies (BsAbs) are rapidly increasing in oncology. While many cancer centers are keeping an eye on this developing field, curiosity must be transformed into…
Innovation in Action: Breaking Down the 2025 ACCC Impact Report
For 52 years, ACCC has brought together thousands of health care professionals from across the nation representing all disciplines in oncology. Today, with over 46,000 members, ACCC's mission remains…
Transforming Palliative Care in Oncology
In this episode of Oncology Unscripted, hosts Mark Liu and Deirdre Saulet speak with 2025 ACCC Innovator Award Winner Andrew Ambort, DO, a palliative care consulting physician at WellSpan Health. Dr.…
Streamlining Access to TIL Cell Therapy for Melanoma
Tumor-infiltrating lymphocyte (TIL) cell therapy is a promising option for patients with advanced melanoma, but logistical and referral challenges can be a barrier to care. In this episode, CANCER…
Policy in Practice: Change Hits the Clinic
Changing regulations are reshaping the practice of oncology. Issues such as prior authorization, shifting coverage policies, reporting mandates, and reimbursement certainty all affect how clinics…
Addressing Psychosocial Distress With Psychedelic-Inspired Therapies
As the number of patients and survivors of cancer grows each year, awareness of the disease's emotional toll—including depression, anxiety, and deep existential distress—is increasingly recognized as…
Set Goals in Today's Health Care Reality
Of the barriers to innovation and adopting new strategies, human hesitation is one of the greatest. Health care is a rapidly evolving field by nature, which is compounded by near constant…
Plans for 2026: A Dialogue With ACCC's Executive Director
In the second installment of Oncology Unscripted, an unfiltered, honest dialogue about the state of cancer care today, hosts Mark Liu and Deirdre Saulet invite Meagan O'Neill, MS, Executive Director…
APPs Paving the Way in Leadership
Advanced practice providers (APPs) are both an integral part of the care team and a driving force behind innovation in oncology. This special state society episode of CANCER BUZZ will explore how…
Training the Next Generation of Oncology Leaders
Cancer cases, cancer-related deaths, and survivorship are projected to rise exponentially—yet oncology faces critical workforce shortages. In this episode, CANCER BUZZ speaks with Tristan Blanco, a…
Introducing Oncology Unscripted
Introducing a brand new podcast from ACCC: Oncology Unscripted. In this inaugural episode, hosts Mark Liu and Deirdre Saulet lay out what listeners can expect from the show, including unfiltered,…
CAR T-Cell Therapy Insights from the Field
CAR T-cell therapy is a potentially life-saving treatment for patients with certain hematologic malignancies. Yet, the logistical challenges and the need for specialized management of adverse events…
Claudin 18.2 Reshaping Gastric Cancer Treatment
Claudin 18.2 is a novel biomarker for advanced gastric and gastroesophageal junction cancer. Patients who test positive for claudin 18.2 may be candidates for the monoclonal antibody, zolbetuximab,…
Frequently Asked Questions
CANCER BUZZ has published 300 episodes since September 2020, covering topics in Science.
CANCER BUZZ is currently highly active with new episodes weekly. Average episode length is 8m.
Sign up on Grep.FM to access contact details for CANCER BUZZ, including email and social media links.
